Virtus LifeSci Biotech Clinical Trials ETF
18 hedge funds and large institutions have $14.7M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 5 closing their positions.
Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
5
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–